These are great news! Sheba hospital is marked by Merck as Phase1 trial hospital, it recently got JCI accreditation. Ella Institute team is very experienced on melanoma immunotherapy.From what I know, MK3475 is already tried there.I only hope there would be a clinical trial to combine MK3475 and Ipillimumab ( and it will also run in Sheba).
Viewing 2 posts - 1 through 2 (of 2 total)
The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.